Ignorer les liens de navigation
Qui sommes nous ? Référence-Recherche Pôle Formation Formation universitaire Formation continue E-Formation Formation en partenariat DPC Documentation & publications Service QRE Sang & Transfusion sanguine Europe & International
 
 


Votre recherche : [La BTT] AUTEUR égal Seifried E
69 résultat(s)


    page 1/3    
 
BTT Bonig H, Schmidt M, Hourfar K, Schuttrumpf J, Seifried E. Sufficient blood, safe blood: can we have both? BMC Med. 2012;10:29.
Thèmes : Aspects réglementaires et management en transfusion ; maj-2012-11
Notice PubMed

BTT Brauninger S, Bialleck H, Thorausch K, Felt T, Seifried E, Bonig H. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems. Transfusion. 2012;52:1137-1145.
Thèmes : Transplantation ; Thérapie cellulaire ; maj-2012-11
Notice PubMed

BTT Meier J, Muller MM, Lauscher P, Sireis W, Seifried E, Zacharowski K. Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient? Transfus Med Hemother. 2012;39:98-103.
Thèmes : Transfusion homologue ; maj-2012-11
Notice PubMed

BTT Mueller MM, Hourfar MK, Huber E, Sireis W, Weichert W, Seifried E, Tonn T, Schmidt M. Oxygen measurements in platelet fluids - a new non-invasive method to detect bacterial contaminations in platelets. Transfus Med. 2012;22:211-216.
Thèmes : Bactéries ; Produits sanguins plaquettaires ; maj-2012-11
Notice PubMed

BTT Muller-Steinhardt M, Weidmann C, Wiesneth M, Weck E, Seifried E, Brade J, Kluter H. Donor Deferral Rates after the Implementation of a New German Blood Donor Questionnaire. Transfus Med Hemother. 2012;39:17-22.
Thèmes : Donneurs et activité de prélèvement ; maj-2012-11
Notice PubMed

BTT Muller-Steinhardt M, Muller-Kuller T, Weiss C, Menzel D, Wiesneth M, Seifried E, Kluter H. Safety and frequency of whole blood donations from elderly donors. Vox Sang. 2012;102:134-139.
Thèmes : Donneurs et activité de prélèvement ; maj-2012-11
Notice PubMed

BTT Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Letowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang. 2012;102:82-90.
Thèmes : Méthodologies diagnostiques ; maj-2012-11
Notice PubMed

BTT Sireis W, Hourfar MK, Seifried E, Schmidt M. How to improve blood safety with respect to bacterial contaminations? Vox Sang. 2012;103:87-88.
Thèmes : Bactéries ; maj-2012-11
Notice PubMed

BTT Stormer M, Arroyo A, Brachert J, Carrero H, Devine D, Epstein JS, Gabriel C, Gelber C, Goodrich R, Hanschmann KM, Heath DG, Jacobs MR, Keil S, De Korte D, Lambrecht B, Lee CK, Marcelis J, Marschner S, McDonald C, McGuane S, McKee M, Muller TH, Muthivhi T, Pettersson A, Radziwon P, Ramirez-Arcos S, Reesink HW, Rojo J, Rood I, Schmidt M, Schneider CK, Seifried E, Sicker U, Wendel S, Wood EM, Yomtovian RA, Montag T. Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox Sang. 2012;102:22-31.
Thèmes : Bactéries ; maj-2012-11
Notice PubMed

BTT Benjamin RJ, Bianco C, Goldman M, Seed CR, Yang H, Lee J, Keller AJ, Wendel S, Biagini S, Murray J, Devine DV, Zhu Y, Turek P, Moftah FM, Kullaste R, Pillonel J, Danic B, Bigey F, Follea G, Seifried E, Mueller MM, Lin CK, Makroo RN, Grazzini G, Pupella S, Velati C, Tadokoro K, Bravo Lindoro A, D'Artote Gonzalez A, Giner VT, Flanagan P, Olaussen RW, Letowska M, Rosiek A, Poglod R, Zhiburt E, Mali P, Rozman P, Gulube S, Castro Izaguirre E, Ekermo B, Barnes SM, McLaughlin L, Eder AF, Panzer S, Reesink HW. Deferral of males who had sex with other males. Vox Sang. 2011;101:339-367.
Thèmes : Donneurs et activité de prélèvement ; maj-2012-02
Notice PubMed

BTT Brauninger S, Bialleck H, Seifried E, Bonig H. Asystole during stem cell apheresis in a young healthy female volunteer donor. Transfusion. 2011;51:1594-1595.
Thèmes : Thérapie cellulaire ; Donneurs et activité de prélèvement ; maj-2012-02
Notice PubMed

BTT Brauninger S, Bialleck H, Thorausch K, Seifried E, Bonig H. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5.0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial. Vox Sang. 2011;101:237-246.
Thèmes : Thérapie cellulaire ; maj-2012-02
Notice PubMed

BTT Henschler R, Seifried E, Mufti N. Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates. Transfus Med Hemother. 2011;38:33-42.
Thèmes : Produits sanguins érythrocytaires ; Inactivation des pathogènes ; maj-2012-02
Notice PubMed

BTT Hourfar MK, Mayr-Wohlfart U, Themann A, Sireis W, Seifried E, Schrezenmeier H, Schmidt M. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion. 2011;51:129-136.
Thèmes : Autres virus ; maj-2011-11

BTT Reinhardt P, Brauninger S, Bialleck H, Thorausch K, Smith R, Schrezenmeier H, Seifried E, Wiesneth M, Bonig H. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device. Transfusion. 2011;51:1321-1330.
Thèmes : Thérapie cellulaire ; maj-2011-11

BTT Rosskopf K, Ragg SJ, Worel N, Gromme M, Preijers FW, Braakman E, Schuurhuis GJ, van Riet I, Wendel S, Fontao-Wendel R, Lazar A, Goldman M, Halpenny M, Giulivi A, Letcher B, McGann L, Korhonen M, Arvola A, Humpe A, Buwitt-Beckmann U, Wiesneth M, Schauwecker P, Schrezenmeier H, Bonig H, Henschler R, Seifried E, Accorsi P, Bonfini T, Takanashi M, van Beckhoven JM, Brand A, Gounder D, Wong A, Dooccey R, Forrest E, Galea G, Smythe J, Pawson R, Reems JA, Oh J, Reesink HW, Panzer S. Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow). Vox Sang. 2011;101:255-275.
Thèmes : Thérapie cellulaire ; maj-2012-02
Notice PubMed

BTT Schmidt M, Sireis W, Seifried E. Implementation of Bacterial Detection Methods into Blood Donor Screening - Overview of Different Technologies. Transfus Med Hemother. 2011;38:259-265.
Thèmes : Bactéries ; maj-2012-02
Notice PubMed

BTT Schmitt A, Tonn T, Busch DH, Grigoleit GU, Einsele H, Odendahl M, Germeroth L, Ringhoffer M, Ringhoffer S, Wiesneth M, Greiner J, Michel D, Mertens T, Rojewski M, Marx M, von Harsdorf S, Dohner H, Seifried E, Bunjes D, Schmitt M. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51:591-599.
Thèmes : Thérapie cellulaire ; maj-2011-11

BTT Seifried E, Klueter H, Weidmann C, Staudenmaier T, Schrezenmeier H, Henschler R, Greinacher A, Mueller MM. How much blood is needed? Vox Sang. 2011;100:10-21.
Thèmes : Aspects réglementaires et management en transfusion ; maj-2011-11 ; Activités de Préparation,Qualification et Distribution

BTT Sireis W, Ruster B, Daiss C, Hourfar MK, Capalbo G, Pfeiffer HU, Janetzko K, Goebel M, Kempf VA, Seifried E, Schmidt M. Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sang. 2011;101:191-199.
Thèmes : Produits sanguins plaquettaires ; maj-2012-02
Notice PubMed

BTT Hintze C, Rüster B, Seifried E, Henschler R. Platelet precursor cells can be generated from cultured human CD34+ progenitor cells but display recirculation into hematopoietic tissue upon transfusion in mice. Transfus Med Hemother. 2010;37:185-190.
Thèmes : Thérapie cellulaire ; maj-2010-11

BTT Klarmann D, Eggert C, Geisen C, Becker S, Seifried E, Klingebiel T, Kreuz W. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents. Transfusion. 2010;50:1571-1580.
Thèmes : Coagulation et fibrinolyse ; Antigènes plaquettaires ; maj-2010-11

BTT Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland O, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang. 2010;98:468-478.
Thèmes : Parasites ; maj-2010-09

BTT Schmidt M, Pichl L, Jork C, Hourfar MK, Schottstedt V, Wagner FF, Seifried E, Muller TH, Bux J, Saldanha J. Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes. Vox Sang. 2010;98:37-46.
Thèmes : Méthodologies diagnostiques ; Donneurs et activité de prélèvement ; maj-2010-04

BTT Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang. 2010;99:1-15.
Thèmes : Produits sanguins plaquettaires ; maj-2010-11

    page 1/3